PRIA Logo™
119-hr-8981119th CongressWALLET

SCALE Biology Act

Sponsored By: Representative McClain Delaney, April [D-MD-6]

In Committee

Summary

Creates a dedicated NIST Biometrology Laboratory Program to fund measurement research, standards, and infrastructure that help engineering biology, biomanufacturing, and biotechnology become more reliable, interoperable, and safe. It focuses on measurement science, data standards, biorisk controls, and tools that help scale lab discoveries into commercial and distributed manufacturing.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

2 provisions identified: 1 benefits, 0 costs, 1 mixed.

NIST biometrology program and funding

This bill would direct the Commerce Secretary, acting through the NIST Director, to set up a Biometrology Laboratory Program to improve measurement science for engineering biology and biomanufacturing. It would authorize up to $55 million for FY2026, $60 million for FY2027, $70 million for FY2028, $78 million for FY2029, and $85 million for FY2030. The bill would let NIST give industry, colleges, nonprofits, and federal, state, and tribal agencies access to NIST user facilities, fund extramural research, coordinate standards work, and support workforce training. The authorization would not itself appropriate money; actual funding would depend on future congressional appropriations, and NIST must publish an implementation plan by the end of the first fiscal year after enactment and a public implementation report within three years.

Repeal of an R&D program provision

This bill would repeal section 10221 of the Research and Development, Competition, and Innovation Act and remove that item from the Act's table of contents. Repealing that section would end whatever program or authority that section created or governed. The bill does not specify replacement funding or transition rules for entities affected by that repeal.

Sponsors & CoSponsors

Sponsor

McClain Delaney, April [D-MD-6]

MD • D

Cosponsors

  • Rep. Obernolte, Jay [R-CA-23]

    CA • R

    Sponsored 5/21/2026

  • Rep. Lofgren, Zoe [D-CA-18]

    CA • D

    Sponsored 5/21/2026

  • Del. Moylan, James C. [R-GU-At Large]

    GU • R

    Sponsored 5/21/2026

  • Rep. Vindman, Eugene Simon [D-VA-7]

    VA • D

    Sponsored 6/15/2026

  • Rep. Ross, Deborah K. [D-NC-2]

    NC • D

    Sponsored 7/13/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation